]>
IRCT20140305016852N4 IRCT 2020-05-04 Sabzevar University of Medical Sciences Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test (Kovid-19) 2020-04-20 anticipated 30 Complete https://irct.ir/trial/47508 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: A random number table is used to randomize. To use the table of random numbers, first to read the numbers of the table will be determined, then the numbers will be considered for different groups. We touch on one of the numbers and move in one of the predefined directions and assign the numbers to different groups, Blinding description: The study will be blinded in two ways. Patients will be blinded by the type of intervention, and the researcher who has to enter the data in the relevant checklist will be blinded by the type of intervention. 2-3 Coronavirus disease (covid-19). Intervention 1: Intervention group: In this group, untreated COVID-19 patients are treated with routine treatments and 50,000 units of vitamin D daily for one week. Intervention 2: Intervention group: In this group, untreated COVID-19 patients are treated with routine and vitamin C-containing treatments containing 500 mg daily for one week. Intervention 3: Control group: The control group includes patients who are under routine care only. Yes - There is a plan to make this available What will be shared: Clinical information (including therapeutic outcomes), laboratory and demographic of Coronavirus patients 2019 under treatment with routine and vitamin D and C When: About 5 to 10 months after the start of the study To whom: Public Conditions: Careful study information can be provided to qualified researchers interested in treating patients. Where to obtain: Corresponding author How to obtain: Competent and enthusiastic researchers can receive data documentation from the responsible author after presenting the work by presenting their academic information and identification. Comments: The clinical trial, titled "Comparison of three therapies in patients with super-acute respiratory syndrome (SARS-COV-2) with and without positive coronavirus testing (Covid-19)", has not been previously reported elsewhere. Not sent elsewhere. We are very happy to have registered our clinical trial on the IRCT website (www.irct.ir). thank you. Wishing you good health and happy moments
public Ebrahim Shirzade
School of medicine-Campus of the University of Medical Sciences-above the memory of the shohadaye gomnam-shohadaye hasteii Boulevard-Sabzevar
Sabzevar Iran (Islamic Republic of) 33787-95196 +98 51 4401 1300 dreshirzad@yahoo.com Sabzevar University of Medical Sciences scientific Somayyeh Nayyeri
Torbat Heydariyeh University of Medical Sciences, Razi St., North Ferdowsi St.
Torbat-Heydariyeh Iran (Islamic Republic of) 33787-95196 +98 51 5222 6013 s.nayyeri86@yahoo.com Torbate-Heidaria University of Medical Sciences Iran (Islamic Republic of) The patient was admitted to the acute respiratory center Consent to participate in the study Age 15 to above Do not take vitamin C and D supplements No gout Lack of kidney and liver disease No pregnancy or lactation No treatment with anti convulsants 15 years no limit Both The patient has lung cancer Patients undergoing chemotherapy and radiotherapy If the patient dies If the patient has a decreased level of consciousness If the patient does not want to continue working on the plan B97.29 Other coronavirus as the cause of diseases classified elsewhere Treatment - Drugs Treatment - Drugs Other Intervention group: In this group, untreated COVID-19 patients are treated with routine treatments and 50,000 units of vitamin D daily for one week. Intervention group: In this group, untreated COVID-19 patients are treated with routine and vitamin C-containing treatments containing 500 mg daily for one week. Control group: The control group includes patients who are under routine care only. Complete recovery of clinical symptoms of 2019 disease. Timepoint: About a week after starting treatment. Method of measurement: Clinical and laboratory questionnaire. Normalization of chest symptoms in CT scan. Timepoint: About 7 to 14 days after starting treatment. Method of measurement: CT scan result. Improving and normalizing the level of laboratory symptoms. Timepoint: At least 1 to 2 weeks after starting treatment. Method of measurement: Laboratory techniques. Sabzevar University of Medical Sciences Approved 2020-04-19 Ethics committee of sabzevar University of Medical Sciences Deputy of Research and Technology-Campus of the University of Medical Sciences-above the memory of the shohadaye gomnam-shohadaye hasteii Boulevard-Sabzevar Sabzevar Razavi Khorasan Iran (Islamic Republic of)